Risk scores in patients with acute coronary syndromes

Original title: Walking Beyond the GRACE (Global Registry of Acute Coronary Events) Model in the Death Risk Stratification During Hospitalization in Patients With Acute Coronary Syndrome. Reference: Rapouseiras-Roubín S, et al. J Am Coll Cardiol Intv 2012;5:1117–25.

Discriminatory power of risk score predictors become fundamental in the management of patients with acute coronary syndromes. This tool lets you define, for example, which patients will benefit most from more aggressive strategies such as early percutaneous revascularization.

Accordingly, several risk scores have been proposed. One of the most widely used in medical practice, the GRACE score, was drafted in 2003 and rapidly became popular owing to its wide applicability. Another widely used score is the one we set in this context; ACTION.

The aim of this study in a single center in Spain was to compare the predictive ability of traditional risk scores, (GRACE and ACTION), with more contemporary scores, (EHS and NCDR). 4,497 consecutive patients were included, of whom 32.1% had MI with ST-segment elevation. Traditional scores from the predictors GRACE and ACTION showed an excellent performance in predicting. Additionally, the more recent prediction scores from NCDR and EHS were not superior to the traditional in this context.

Conclusion 

The GRACE score remains a tool with great clinical applicability for the prediction of adverse cardiovascular events in patients with acute coronary syndromes.

Editorial Comment:

The major limitation of the study lies in the fact it came from a single center whose inclusion of patients was performed consecutively. However, the significant number of patients included allows generalizing the conclusion (external validity) that the GRACE score remains one of the most useful tools for predicting cardiovascular risk in patients with acute coronary syndromes.

Courtesy of Dr. Marco Wainstein
Editorial Board Member

Dr. Marco Wainstein

More articles by this author

Bioresorbable devices vs DES in patients at high risk of restenosis. Seven-year follow-up of the COMPARE-ABSORB trial

Studies with second-generation drug-eluting stents (DES) have shown that the rate of target lesion failure (TLF) increases linearly up to 5–10 years of follow-up,...

Sheathless Femoral Impella: A New Strategy to Reduce Vascular Complications in High-Risk PCI?

Patients with complex coronary artery disease or cardiogenic shock undergoing percutaneous coronary intervention (PCI) may benefit from the hemodynamic support provided by percutaneous ventricular...

OCT- and IVUS-Guided Coronary Angioplasty in Acute Coronary Syndrome: Long-Term Clinical Outcomes

Percutaneous coronary angioplasty (PCI) in patients with acute coronary syndrome (ACS) has reduced mortality in the acute phase. However, recurrent ACS and target vessel...

Rolling Stone: Registry of Intravascular Lithotripsy vs Atherectomy Use in Complex Calcified Lesions

Severe coronary calcification represents one of the main challenges in performing percutaneous coronary intervention, both due to the higher risk of stent underexpansion and...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

Bioresorbable devices vs DES in patients at high risk of restenosis. Seven-year follow-up of the COMPARE-ABSORB trial

Studies with second-generation drug-eluting stents (DES) have shown that the rate of target lesion failure (TLF) increases linearly up to 5–10 years of follow-up,...

Low-Dose Rivaroxaban After Peripheral Angioplasty: Effectiveness and Safety in Real-World Clinical Practice

Following lower limb revascularization, optimal medical therapy includes antiplatelet agents, high-intensity statins, and control of cardiovascular risk factors. Recent studies such as COMPASS and...

Sheathless Femoral Impella: A New Strategy to Reduce Vascular Complications in High-Risk PCI?

Patients with complex coronary artery disease or cardiogenic shock undergoing percutaneous coronary intervention (PCI) may benefit from the hemodynamic support provided by percutaneous ventricular...